Clinical Trial Update: Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC [NA]

View source ↗

Summary

This registry entry describes a clinical study evaluating pembrolizumab in combination with microwave ablation (MWA) for advanced non-small cell lung cancer, wh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Non Small Cell Lung Cancer | NA | Status: RECRUITING